Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 365.23-83.7020.61100.96-42.28

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 365.23 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023365.23
Mar2022-83.70
Mar202120.61
Mar2020100.96
Mar2019-42.28

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2023 365.23
Positive
Mar2022 -83.7
Negative
Mar2021 20.61
-79.59
Mar2020 100.96
Positive
Mar2019 -42.28 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹8,118.9 Cr 0.8% 10% 163.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

0.8%

10%

163.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses